Tags |
|
|
Links |
|
|
Main Subject - When Networking Stop Selling to Salesmen
If you enjoy going to networking business social gatherings or Cham
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ber of Commerce Mixers as a way to develop a referral network and h
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ave some fun and do a little business then you need to stop trying
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
o sell so hard to other salesmen and start talking about how you tw
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
o can work together in a common cause, sharing information, custome
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
databases and business card stacks. Why?
Well, because one salesm
Well, because one salesm
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
en at a business meeting is not going to make your year most likely
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
for your sales goals, but one sales person who is on the ball may
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
now 50 people who could in fact give you a good running start at ac
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
hieving your sales objectives. So, stop trying to sell to other sal
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
speople at networking gatherings and start discussing how you might
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
work together to achieve both your objectives.
Ask the other part
Ask the other part
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
y to tell you the advantages of all of their products or services a
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
d what type of prospect that they are really looking for and tell t
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
hem of your target customer as well and then share information abou
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
who you know that they wish to know and vice versa.
This is a gam
This is a gam
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
e about synergy and sales are a lot about getting yourself in front
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
of the decision maker who is so elusive. Referral networks work, b
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
t only if you stop trying to sell to salespeople and start using th
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e networking tool like it should be used. Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31864/mainsubjects-When-Networking-Stop-Selling-to-Salesmen.html">When Networking Stop Selling to Salesmen</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31864/mainsubjects-When-Networking-Stop-Selling-to-Salesmen.html]When Networking Stop Selling to Salesmen[/url]
Related Articles:
Career Success Factors: 5 Simple Ways for a Career Boost
Bookmark it:
|